Shorter time between first medical contact to PCI in heart patients linked to saving lives

February 14, 2018, European Society of Cardiology

Heart experts are calling for immediate action following new research that shows every minute counts for patients who suffer the most severe type of heart attack. The study shows numbers of deaths rise steadily and rapidly the longer the time between patients' first contact with a medical professional and when they are treated in hospital with percutaneous coronary intervention (PCI) to insert a balloon catheter to widen blocked arteries and restore blood flow to the heart.

Until now, little was known about the impact on survival of the length of time from first medical contact (usually the ) to balloon insertion for patients with ST-segment elevation myocardial infarction (STEMI) in unstable clinical condition. But research published today (Wednesday) in the European Heart Journal shows that for STEMI patients who have cardiogenic shock (when the heart suddenly can't pump enough blood to meet the body's needs), every ten-minute delay in treatment means there will be an extra 3.3 deaths per 100 patients treated with PCI.

The researchers found a steep increase in deaths the longer it took for patients to receive PCI and that one death in every 12 patients could be prevented when they were treated within the recommended time of less than 90 minutes. A fifth of all patients who received PCI between 150 to 180 minutes after their first contact with a medical professional died.

The research was carried out in 12,675 patients with STEMI - the most severe type of heart attack where part of the heart muscle has died due to lack of blood supply - who used emergency medical services transportation to hospital and were treated with PCI in Germany between 2006 and 2015.

Professor Karl Heinrich Scholz, head of the Department of Cardiology at St Bernward Hospital at Hildesheim (Germany), who led the research, said: "The most important finding of our study is that STEMI patients presenting with cardiogenic shock are more likely to survive if they receive rapid . In this high-risk patient group, every ten-minute treatment delay was accompanied by 3.3 additional deaths, and this treatment-delay-related increase in mortality was ten-fold higher as compared to STEMI patients presenting with more stable conditions. This means that, especially in shock patients and in patients with cardiac arrest, maximum efforts are necessary to optimise processes of care to shorten the time to treatment and improve their outcome."

In an editorial to accompany the paper, Professor William Wijns of the Lambe Institute for Translational Medicine and Curam at the National University of Ireland, (Galway, Ireland), and Professor Christoph Naber of University Hospital Essen (Germany), write: "The importance of this work cannot be overemphasized.....The present data demonstrate that time matters even more than we are used to think...The present data call for immediate action....Reducing treatment delays as much as possible in all, but especially in patients with CS [cardiogenic shock] and/or OHCA [out-of-hospital cardiac arrest], should be our immediate next objective."

Prof Scholz and his colleagues analysed data from the Feedback Intervention and Treatment Times in ST-Elevation Myocardial Infraction (FITT-STEMI) trial which, by 2015, involved 48 hospitals throughout Germany. Prof Scholz started the trial and is the principal investigator. All the hospitals had to be capable of carrying out PCI, and all STEMI patients arriving at the hospitals between January 2006 and 30 November 2015 were enrolled in the trial. Patients who were treated within 360 minutes from the time of first contact with a medical professional were included in the analysis.

Death rates among the STEMI patients were 3% in those with a stable condition, 16% in those who had an out-of-hospital cardiac arrest but were stable, 39% in patients with cardiogenic shock, and 45% in patients who had an out-of-hospital cardiac arrest and cardiogenic shock.

When the emergency medical services (EMS) are called out to a patient with a suspected in Germany, a doctor trained in emergency medicine accompanies them. This enables a diagnosis to be made promptly and the doctor can call ahead to the nearest hospital with an on-call PCI team so that they can be ready to treat the patient the moment he or she arrives. This can save more than 15 minutes in time to treatment. Bypassing the emergency department and going straight to the PCI team saved an average of 33 minutes in this study.

Not all European countries have this system, but Prof Scholz says: "To my knowledge, other European countries include doctors in emergency medical services transportation teams, such as France, Italy, Austria, Poland, Hungary and Denmark. Norway has established physician-manned helicopter transportation, and some other countries may have a few physician-manned ambulances, for example Switzerland."

But regardless of what EMS transportation system is used, Prof Scholz says the results from the study apply everywhere. "Our results clearly indicate that, in patients with acute STEMI, the time from first medical contact to restoring blood flow via balloon insertion is a strong predictor of survival. Any effort to shorten this time interval is beneficial for STEMI patients. Given that other health services have similar sophisticated EMS teams and high numbers of PCI centres, I believe that our results in patients with cardiogenic shock can be extrapolated to many other European countries. However, regardless of whether or not the EMS are physician-manned or exclusively paramedics-staffed, maximum efforts are needed to shorten the time from first medical contact to balloon insertion in all STEMI patients, especially in those presenting with shock.

"To this end, it is important to avoid transportation of STEMI patients to unsuitable hospitals without PCI capability, and to circumvent admission to emergency departments or intensive care units, which will all delay the time to PCI treatment."

The way patients are taken to hospital is one of the limitations of the study in terms of its applicability to other countries. Other limitations of the study include the fact that patients who died may have been sicker than those who survived; that the study can only show an association between time to treatment and the chances of survival, not that one causes the other; that there may be unknown factors that might affect the results such as the quality of chest compressions and other additional treatments; and that the researchers do not know how the introduction of standardised data assessment and systematic interactive feedback to all staff in hospitals participating in the trial might have benefitted patients in this trial compared to those treated elsewhere.

Prof Scholz concludes: "We believe that quality improvement measures with standardised data registration, systematic analysis and interactive feedback, which are all important components of the FITT-STEMI study protocol, should be implemented in all local treatment networks in order to maintain a long-lasting impact on mortality in all STEMI ."

Explore further: '09 to '15 saw increase in transradial access for STEMI PCI

More information: Karl Heinrich Scholz et al, Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial, European Heart Journal (2018). DOI: 10.1093/eurheartj/ehy004

William Wijns et al. Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected, European Heart Journal (2018). DOI: 10.1093/eurheartj/ehy069

Related Stories

'09 to '15 saw increase in transradial access for STEMI PCI

November 3, 2017
(HealthDay)—Use of transradial access (TRA) for ST-elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI) increased from 2009 to 2015, with considerable geographic, operator, and institutional ...

WhatsApp use by Argentina ambulances associated with faster heart attack treatment

October 19, 2017
WhatsApp use by ambulance doctors in Argentina was associated with faster treatment of heart attack and lower mortality in an observational study presented today at the Argentine Congress of Cardiology (SAC 2017). The free ...

Patients who have STEMI heart attacks while hospitalized more likely to die

April 17, 2013
(Medical Xpress)—If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for ...

Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

October 31, 2017
Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found that an initial strategy of culprit lesion only percutaneous coronary intervention (PCI) reduces the composite of 30-day mortality and/or severe ...

No advantage of ambulance over hospital anti-clot therapy for heart attack patients

August 29, 2017
In contrast to European and American guidelines that recommend pre-hospital antiplatelet therapy for heart attack patients suffering from ST-elevation myocardial infarction (STEMI), a new study presented at ESC Congress suggests ...

Heart attack patients taken to PCI hospitals first treated faster

May 10, 2012
Heart attack patients in North Carolina who were rushed directly to hospitals equipped to do percutaneous coronary intervention (PCI) received treatment significantly faster than patients first taken to hospitals unequipped ...

Recommended for you

Drug now in clinical trials for Parkinson's strengthens heart contractions in animals

July 20, 2018
A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

'Good cholesterol' may not always be good

July 19, 2018
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) - also known as 'good cholesterol' - according to a study led by researchers in the University of Pittsburgh Graduate ...

Using adrenaline in cardiac arrests results in less than 1 percent more people leaving hospital alive

July 18, 2018
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive—but almost doubles the risk of severe brain damage for survivors of cardiac ...

Omega 3 supplements have little or no heart or vascular health benefit: review

July 17, 2018
New evidence published today shows there is little or no effect of omega 3 supplements on our risk of experiencing heart disease, stroke or death.

Researchers discover new genes associated with heart function

July 17, 2018
A new study from an international research team, led by Dr. Yalda Jamshidi at St George's, University of London, has identified new genes associated with heart function and development.

Southern diet could be deadly for people with heart disease

July 12, 2018
People with a history of heart disease who eat a traditional Southern diet are more likely to die than those who follow a Mediterranean dietary pattern, according to new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.